Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections-Reference-Cited by-同舟云学术

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections

Published:2016-12-17 Issue:1 Volume:77 Page:75-83
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Garnock-Jones Karly P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-016-0666-0.pdf

Reference42 articles.

1. Juul JJ, Mullins CF, Peppard WJ, et al. New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin. Ther Clin Risk Manag. 2016;12:225–32.

2. Leuthner KD, Buechler KA, Kogan D, et al. Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Ther Clin Risk Manag. 2016;12:931–40.

3. Van Bambeke F. Lipoglycopeptide antibacterial agents in Gram-positive infections: a comparative review. Drugs. 2015;75(18):2073–95.

4. Durata Therapeutics US Ltd. Dalvance® (dalbavancin for injection, for intravenous use): US prescribing information. 2016. http://www.allergan.com . Accessed 11 Nov 2016.

5. European Medicines Agency. Xydalba® (dalbavancin powder for concentrate for solution for infusion): EU summary of product characteristics. 2016. http://www.ema.europa.eu . Accessed 11 Nov 2016.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy;BMC Infectious Diseases;2024-09-02

2. Unraveling novel Mutation Patterns and Morphological Variations in Two Dalbavancin-resistant MRSA strains in Austria using Whole Genome Sequencing and Transmission Electron Microscopy;2024-02-14

3. Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis;Journal of Infection and Public Health;2023-06

4. Dalbavancin in clinical practice in Spain: a 2 year retrospective study;JAC-Antimicrobial Resistance;2022-11-03

5. Real world utilization of Dalbavancin at a rural community emergency department;The American Journal of Emergency Medicine;2022-04